Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
VanEck Semiconductor ETF
SMH
$65.9B
| $2.91M | ﹤0.01% |
54,686
+36,678
| +204% | +$1.82M |
|
2127
Wave Life Sciences
WVE
$1.03B
| $2.91M | ﹤0.01% |
74,838
+60,721
| +430% | +$2.46M |
|
|
STI
2128
DELISTED
SunTrust Banks, Inc.
STI
| $2.9M | ﹤0.01% |
49,013
-618,918
| -93% | -$37.9M |
|
2129
Leidos
LDOS
$17.2B
| $2.9M | ﹤0.01% |
45,256
+31,932
| +240% | +$1.93M |
|
2130
PUT
Starbucks
SBUX
$124B
| $2.9M | ﹤0.01% |
39,000
-376,000
| -91% | -$25.8M |
|
|
CORE
2131
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.9M | ﹤0.01% |
78,026
-125,005
| -62% | -$3.93M |
|
|
CVGW
2132
DELISTED
Calavo Growers
CVGW
| $2.9M | ﹤0.01% |
+34,537
| New | +$2.8M |
|
|
ONC
2133
CALL
BeOne Medicines Ltd
ONC
$42.5B
| $2.89M | ﹤0.01% |
+21,900
| New | +$2.95M |
|
2134
TriplePoint Venture Growth BDC
TPVG
$217M
| $2.88M | ﹤0.01% |
209,422
-198,637
| -49% | -$2.53M |
|
2135
iShares Select Dividend ETF
DVY
$24B
| $2.88M | ﹤0.01% |
29,344
+20,140
| +219% | +$1.93M |
|
2136
Globe Life
GL
$13.5B
| $2.88M | ﹤0.01% |
35,152
+20,235
| +136% | +$1.65M |
|
2137
Enel Chile
ENIC
$6.18B
| $2.88M | ﹤0.01% |
554,982
-96,820
| -15% | -$505K |
|
|
BHBK
2138
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $2.88M | ﹤0.01% |
+120,277
| New | +$2.82M |
|
2139
PUT
Albemarle
ALB
$15.9B
| $2.87M | ﹤0.01% |
35,000
-50,700
| -59% | -$4.15M |
|
|
DX
2140
Dynex Capital
DX
$3.2B
| $2.87M | ﹤0.01% |
157,056
-140,463
| -47% | -$2.57M |
|
2141
Federal Signal
FSS
$7.42B
| $2.87M | ﹤0.01% |
110,324
-348,234
| -76% | -$7.96M |
|
2142
CALL
CSX Corp
CSX
$95.9B
| $2.87M | ﹤0.01% |
+114,900
| New | +$2.66M |
|
2143
CALL
Regenxbio
RGNX
$619M
| $2.87M | ﹤0.01% |
+50,000
| New | +$2.48M |
|
2144
PUT
KBR
KBR
$4.78B
| $2.86M | ﹤0.01% |
+150,000
| New | +$2.71M |
|
|
ASAP
2145
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $2.86M | ﹤0.01% |
+11,627
| New | +$2.78M |
|
2146
Philips
PHG
$26.4B
| $2.86M | ﹤0.01% |
90,037
+7,705
| +9% | +$229K |
|
2147
Elastic
ESTC
$8.24B
| $2.85M | ﹤0.01% |
35,617
+32,453
| +1,026% | +$2.71M |
|
|
JCAP
2148
DELISTED
Jernigan Capital, Inc.
JCAP
| $2.85M | ﹤0.01% |
135,228
-23,855
| -15% | -$507K |
|
|
NUVA
2149
CALL
DELISTED
NuVasive, Inc.
NUVA
| $2.84M | ﹤0.01% |
50,000
+40,000
| +400% | +$2.13M |
|
2150
Inseego
INSG
$74.2M
| $2.84M | ﹤0.01% |
60,113
+30,823
| +105% | +$1.57M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.